Clinical Characteristics of Adults with Self-reported Diagnosed Asthma And/or COPD: Data from the BOLD Australia Study

Overview

Journal ERJ Open Res

Specialty Pulmonary Medicine

Date 2023 Aug 23

PMID 37609600

Authors

Yijun Zhou

Maria R Ampon

Michael J Abramson

Alan L James

Graeme P Maguire

Richard Wood-Baker

David P Johns

Guy B Marks

Helen K Reddel

Brett G Toelle

Affiliations

Soon will be listed here.

Abstract

Background: Diagnosis of asthma and chronic obstructive pulmonary disease (COPD) in the community is variable, often without spirometry. Some studies report that adults with both diagnostic labels (asthma+COPD) have worse health outcomes than those with asthma or COPD only, but data for Australian adults are limited. We investigated the relationship between clinical characteristics and self-reported diagnoses of asthma, COPD and both.

Method: We used data from the BOLD Australia study, which included randomly selected adults aged ≥40 years from six study sites. The BOLD questionnaires and spirometry test were used in all sites. Participants were grouped by self-reported diagnosis. Demographic and clinical characteristics and lung function were compared between groups.

Results: Of the study sample (n=3522), 336 reported asthma only, 172 reported COPD only, 77 reported asthma+COPD and 2937 reported neither. Fewer than half of participants with a COPD diagnosis (with or without asthma) had airflow limitation. Participants with asthma+COPD had more respiratory symptoms and greater airflow limitation than those with either diagnosis alone. Having asthma+COPD was independently associated with a higher probability of having clinically important breathlessness (modified Medical Research Council score ≥2) than asthma only (adjusted OR 3.44, 95% CI 1.86-6.33) or COPD only (adjusted OR 3.28, 95% CI 1.69-6.39). Airflow limitation (Global Initiative for Chronic Obstructive Lung Disease 2 or higher, using post-bronchodilator forced expiratory volume in 1 s/forced vital capacity ratio <0.7) was similar between asthma only and COPD only, but twice as prevalent in asthma+COPD (adjusted OR 2.18 and 2.58, respectively).

Conclusions: Adults with diagnoses of asthma+COPD have a higher symptom and disease burden than those with diagnoses of asthma only or COPD only. These patients should receive regular comprehensive reviews because of the substantially increased burden of having both diagnoses.

References

Ding B, DiBonaventura M, Karlsson N, Ling X . Asthma-chronic obstructive pulmonary disease overlap syndrome in the urban Chinese population: prevalence and disease burden using the 2010, 2012, and 2013 China National Health and Wellness Surveys. Int J Chron Obstruct Pulmon Dis. 2016; 11:1139-50. PMC: 4907484. DOI: 10.2147/COPD.S103873. View

Tan D, Lodge C, Lowe A, Bui D, Bowatte G, Johns D . Bronchodilator reversibility as a diagnostic test for adult asthma: findings from the population-based Tasmanian Longitudinal Health Study. ERJ Open Res. 2021; 7(1). PMC: 7869605. DOI: 10.1183/23120541.00042-2020. View

Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7):581-6. PMC: 1745516. DOI: 10.1136/thx.54.7.581. View

Kendzerska T, Aaron S, To T, Licskai C, Stanbrook M, Vozoris N . Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study. Ann Am Thorac Soc. 2019; 16(10):1252-1262. DOI: 10.1513/AnnalsATS.201902-126OC. View

Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A . Standardisation of spirometry. Eur Respir J. 2005; 26(2):319-38. DOI: 10.1183/09031936.05.00034805. View

Matheson M, Abeysena C, Raven J, Skoric B, Johns D, Abramson M . How have we been managing chronic obstructive pulmonary disease in Australia?. Intern Med J. 2006; 36(2):92-9. DOI: 10.1111/j.1445-5994.2006.01011.x. View

Quanjer P, Stanojevic S, Cole T, Baur X, Hall G, Culver B . Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012; 40(6):1324-43. PMC: 3786581. DOI: 10.1183/09031936.00080312. View

Diab N, Gershon A, Sin D, Tan W, Bourbeau J, Boulet L . Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018; 198(9):1130-1139. DOI: 10.1164/rccm.201804-0621CI. View

. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1204-1222. PMC: 7567026. DOI: 10.1016/S0140-6736(20)30925-9. View

10.

Buist A, Vollmer W, Sullivan S, Weiss K, Lee T, Menezes A . The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD. 2006; 2(2):277-83. View

11.

Reddel H . Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone?. J Allergy Clin Immunol. 2015; 136(3):546-52. DOI: 10.1016/j.jaci.2015.06.043. View

12.

Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589):741-50. DOI: 10.1016/S0140-6736(07)61377-4. View

13.

Alshabanat A, Zafari Z, Albanyan O, Dairi M, Fitzgerald J . Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis. PLoS One. 2015; 10(9):e0136065. PMC: 4559416. DOI: 10.1371/journal.pone.0136065. View

14.

Gershon A, Campitelli M, Croxford R, Stanbrook M, To T, Upshur R . Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease. JAMA. 2014; 312(11):1114-21. DOI: 10.1001/jama.2014.11432. View

15.

Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R . Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5):948-68. DOI: 10.1183/09031936.05.00035205. View

16.

Brown T, Jones T, Gove K, Barber C, Elliott S, Chauhan A . Randomised controlled trials in severe asthma: selection by phenotype or stereotype. Eur Respir J. 2018; 52(6). DOI: 10.1183/13993003.01444-2018. View

17.

Izbicki G, Teo V, Liang J, Russell G, Holland A, Zwar N . Clinical Characteristics Of Patients With Asthma COPD Overlap (ACO) In Australian Primary Care. Int J Chron Obstruct Pulmon Dis. 2019; 14:2745-2752. PMC: 6899160. DOI: 10.2147/COPD.S220346. View

18.

Park S, Jung H, Kim J, Seo B, Kwon O, Choi S . Longitudinal analysis to better characterize Asthma-COPD overlap syndrome: Findings from an adult asthma cohort in Korea (COREA). Clin Exp Allergy. 2019; 49(5):603-614. DOI: 10.1111/cea.13339. View

19.

Menezes A, Montes de Oca M, Perez-Padilla R, Nadeau G, Wehrmeister F, Lopez-Varela M . Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2013; 145(2):297-304. DOI: 10.1378/chest.13-0622. View

20.

Toelle B, Xuan W, Bird T, Abramson M, Atkinson D, Burton D . Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust. 2013; 198(3):144-8. DOI: 10.5694/mja11.11640. View